supp.fit

Omega-3 Fatty Acids and Vitamin A: study protocols

12 study groups took Omega-3 Fatty Acids together with Vitamin A. These are the doses the studies gave. They are not a recommendation.

Omega-3 Fatty Acids: what the research found →

Dose per serving from research: Omega-3 Fatty Acids

12 study groups in 10 studies say how much Omega-3 Fatty Acids participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 500 mg to 1 g, 33% of 12 study groups.

Daily doseStudy groups
100 mg to 250 mg
2
250 mg to 500 mg
1
500 mg to 1 g
4
1 g to 2.5 g
1
2.5 g to 5 g
3
5 g to 10 g
1

Dose per serving from research: Vitamin A

9 study groups in 8 studies say how much Vitamin A participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 500 mcg to 1 mg, 44% of 9 study groups.

Daily doseStudy groups
100 mcg to 250 mcg
2
250 mcg to 500 mcg
3
500 mcg to 1 mg
4

Commonly used together

12 of 12 study groups took Omega-3 Fatty Acids and Vitamin A with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Vitamin E
8
Vitamin C
6
Zinc
6
Copper
4
Docosahexaenoic Acid
4

12 study groups

Study
TOZAL Study: an open case control study of an oral antioxidant and omega-3 supplement for dry AMD
2007 · Sham MCS and nutritional supplement · Adults aged 50–90 with dry age-related macular degeneration in at least one eye
300 mg10,000 IU24 weeks37
A randomized, double-masked study to evaluate the effect of omega-3 fatty acids supplementation in meibomian gland dysfunction
2013 · Group B (study oral supplement formulation, Brudysec 1.5 g) · Adults aged 23–85 years, both sexes, diagnosed with meibomian gland dysfunction
1.27 g400 mcg90 days33
The Effects of Specific Omega-3 and Omega-6 Polyunsaturated Fatty Acids and Antioxidant Vitamins on Gait and Functional Capacity Parameters in Patients with Relapsing-Remitting Multiple Sclerosis
2021 · OMEGA group · Adults with relapsing-remitting multiple sclerosis; mean age 38.4 years (SD 7.1)
4.95 g600 mcg2 years27
Clinical and microbiological outcomes of subgingival instrumentation supplemented with high-dose omega-3 polyunsaturated fatty acids in periodontal treatment - a randomized clinical trial
2023 · Test group (SRP plus fish oil) · Adults aged 22–70 with generalized stage III or IV periodontitis
2.6 g240 mcg26 weeks24
The Effects of a 6-Month High Dose Omega-3 and Omega-6 Polyunsaturated Fatty Acids and Antioxidant Vitamins Supplementation on Cognitive Function and Functional Capacity in Older Adults with Mild Cognitive Impairment
2020 · omega supplementation group · Adults aged 65 years or older with mild cognitive impairment
810 mg600 mcg26 weeks23
Omega-3 Polyunsaturated Fatty Acids EPA and DHA as an Adjunct to Non-Surgical Treatment of Periodontitis: A Randomized Clinical Trial
2020 · Test group · Adults aged 22–70 with generalized stage III or IV periodontitis
2.6 g240 mcg90 days20
Neuroaspis PLP10™, a nutritional formula rich in omega-3 and omega-6 fatty acids with antioxidant vitamins including gamma-tocopherol in early Parkinson's disease: A randomized, double-blind, placebo-controlled trial
2021 · Neuroaspis PLP10™ · Patients with Parkinson's disease; age and sex not reported.
810 mg600 mcg913 days20
Effects of Supplementation with Omega-3 and Omega-6 Polyunsaturated Fatty Acids and Antioxidant Vitamins, Combined with High-Intensity Functional Training, on Exercise Performance and Body Composition: A Randomized, Double-Blind, Placebo-Controlled Trial
2024 · experimental supplement group (SG) · Healthy young adult women and men, aged approximately 29 years, familiar with high-intensity functional training and with at least 6 months of similar exercise experience
6.9 g600 mcg8 weeks10
Effect of a 12-mo micronutrient intervention on learning and memory in well-nourished and marginally nourished school-aged children: 2 parallel, randomized, placebo-controlled studies in Australia and Indonesia
2007 · Australia micronutrient mix plus DHA+EPA · Children aged 6–10 years in Australia, described as well-nourished
110 mg—1 year—
Effect of a 12-mo micronutrient intervention on learning and memory in well-nourished and marginally nourished school-aged children: 2 parallel, randomized, placebo-controlled studies in Australia and Indonesia
2007 · Indonesia micronutrient mix plus DHA+EPA · Children aged 6–10 years in Indonesia, described as marginally nourished
110 mg—1 year—
Effects of a nutraceutical formulation based on the combination of antioxidants and ω-3 essential fatty acids in the expression of inflammation and immune response mediators in tears from patients with dry eye disorders
2013 · DEDG+S · Adults aged 23–80 years, both sexes, with mild-to-moderate dry eye disorders
845 mg267 mcg90 days—
Effects of a nutraceutical formulation based on the combination of antioxidants and ω-3 essential fatty acids in the expression of inflammation and immune response mediators in tears from patients with dry eye disorders
2013 · CG+S · Healthy adults aged 23–80 years, both sexes
845 mg267 mcg90 days—
Omega-3 Fatty Acids and Vitamin A: study protocols | supp.fit